Scientific approach · Time to Truth
The market does not care about founder intuition. We install the radar that RCTs showed separates winners from zombies—and from expensive accidental deaths.
Camuffo, Gambardella and co-authors trained founders to act like scientists: written theories, explicit hypotheses, pre-committed metrics—then tracked them against intuition-led peers.
01
A 3% conversion is not “early traction” if you said you needed 15%. Science-led teams recognise failure; gut-led teams fund zombies.
02
Fewer pivots, but radical and clean. Keep the core vision; change product, segment, or value prop—not everything at once.
03
Similar early closure rates (~20%) hide opposite stories: accidental death at €0 vs intentional termination with runway intact—and more shots on goal.
Maqqa does not sell psychic market prediction. We sell Time-to-Truth: the system that turns a roadmap into falsifiable bets, measures them against wallets and behaviour, and forces Scale, Pivot, or Terminate—before the slow grind to zero.
If you ship the next initiative by gut, you risk months of build budget on a maladapted idea. Our fee is a fraction of that. If the idea wins, we scale on clean data. If it loses, we kill it early—having spent a test budget, not a funeral budget.
We apply the mechanism to SaaS roadmaps; we do not claim affiliation with the authors. Free practice: That’s bollocks — an anti-sycophancy challenger for your next bet.
Bring the next feature or MVP. Leave with Scale, Pivot, Kill—or the right offer.